摘要
Tetrahydrohyperforin (IDN5706)是源于贯叶金丝桃素(IDN5522)的半合成化合物,它是圣约翰草的主要活性成分。对野生型和双转基因(APPswe/PSEN1ΔE)阿尔茨海默病小鼠模型给药时,IDN5706显示了许多有益效果。然而,它的作用机制目前仍是未知的。为了这个目标,我们分析了IDN5706 和现存的TRPC3/6/7激活物1-油酰基-2-乙酰基-sn-丙三醇(OAG)、TRPC通道阻滞剂SKF96365和神经毒性β-淀粉样蛋白(Aβ)寡聚物和培养的小鼠海马切片场兴奋性突触后电位(fEPSPs)。为了研究空间记忆,用IDN5706 and SKF96365治疗的野生型小鼠进行了水迷宫行为测试。计算机模拟研究旨在预测潜在的药效。IDN5706 and OAG对 fEPSPs 具有相似的刺激作用,由SKF96365进行抑制。IDN5706可以保护减少β-淀粉样蛋白低聚物诱导的fEPSPs。IDN5706能改善野生型小鼠的空间记忆,联合服用SKF96365会阻碍其作用。我们的计算机模拟研究提示IDN5706和其它已经报道的TRPC6激活物(IDN5522, OAG and Hyp9)有强大的药效团相似性。我们认为IDN5706 效应是由通道亚家族TRPC3/6/7进行调节。针对IDN5706在阿尔茨海默病临床应用药物作用机制的公开是一个必然的步骤。
关键词: β-淀粉样蛋白寡聚物,阿尔茨海默病,神经保护作用,海马,tetrahydrohyperforin,TRPC通道。
Current Medicinal Chemistry
Title:Effects of Tetrahydrohyperforin in Mouse Hippocampal Slices: Neuroprotection, Long-term Potentiation and TRPC Channels
Volume: 21 Issue: 30
Author(s): C. Montecinos-Oliva, A. Schuller, J. Parodi, F. Melo and N.C. Inestrosa
Affiliation:
关键词: β-淀粉样蛋白寡聚物,阿尔茨海默病,神经保护作用,海马,tetrahydrohyperforin,TRPC通道。
摘要: Tetrahydrohyperforin (IDN5706) is a semi-synthetic compound derived from hyperforin (IDN5522) and is the main active principle of St. John’s Wort. IDN5706 has shown numerous beneficial effects when administered to wild-type and double transgenic (APPswe/PSEN1ΔE9) mice that model Alzheimer’s disease. However, its mechanism of action is currently unknown. Toward this end, we analysed field excitatory postsynaptic potentials (fEPSPs) in mouse hippocampal slices incubated with IDN5706 and in the presence of the TRPC3/6/7 activator 1-oleoyl-2-acetyl-sn-glycerol (OAG), the TRPC channel blocker SKF96365, and neurotoxic amyloid β-protein (Aβ) oligomers. To study spatial memory, Morris water maze (MWM) behavioural tests were conducted on wild-type mice treated with IDN5706 and SKF96365. In silico studies were conducted to predict a potential pharmacophore. IDN5706 and OAG had a similar stimulating effect on fEPSPs, which was inhibited by SKF96365. IDN5706 protected from reduced fEPSPs induced by Aβ oligomers. IDN5706 improved spatial memory in wild-type mice, an effect that was counteracted by co-administration of SKF96365. Our in silico studies suggest strong pharmacophore similarity of IDN5706 and other reported TRPC6 activators (IDN5522, OAG and Hyp9). We propose that the effect of IDN5706 is mediated through activation of the TRPC3/6/7 channel subfamily. The unveiling of the drug’s mechanism of action is a necessary step toward the clinical use of IDN5706 in Alzheimer’s disease.
Export Options
About this article
Cite this article as:
Montecinos-Oliva C., Schuller A., Parodi J., Melo F. and Inestrosa N.C., Effects of Tetrahydrohyperforin in Mouse Hippocampal Slices: Neuroprotection, Long-term Potentiation and TRPC Channels, Current Medicinal Chemistry 2014; 21 (30) . https://dx.doi.org/10.2174/0929867321666140716091229
DOI https://dx.doi.org/10.2174/0929867321666140716091229 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer
Recent Patents on Biotechnology The Key microRNAs Regulated the Development of Non-small Cell Lung Cancer by Targeting TGF-β-induced epithelial–mesenchymal Transition
Combinatorial Chemistry & High Throughput Screening Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Current Genomics Personalized Medicine in Oncology: A Personal View with Myths and Facts
Current Clinical Pharmacology Mechanisms Underlying Chemopreventive Effects of Flavonoids via Multiple Signaling Nodes within Nrf2-ARE and AhR-XRE Gene Regulatory Networks
Current Chemical Biology Trifluoroibuprofen Inhibits α-Methylacyl Coenzyme A Racemase (AMACR/P504S), Reduces Cancer Cell Proliferation and Inhibits in vivo Tumor Growth in Aggressive Prostate Cancer Models
Anti-Cancer Agents in Medicinal Chemistry Sulfotransferase 1A1 as a Biomarker for Susceptibility to Carcinogenesis: From Molecular Genetics to the Role of Dietary Flavonoids
Current Drug Metabolism Editorial: (Thematic Issue): The Pathogenesis of Inflammation and Cancer in the Gastrointestinal Tract: From Basic Science to Translational Medicine
Current Pharmaceutical Design Magnetic Nanoparticles: New Players in Antimicrobial Peptide Therapeutics.
Current Protein & Peptide Science MDM2 Increases Drug Resistance in Cancer Cells by Inducing EMT Independent of p53
Current Medicinal Chemistry Prostaglandins Pathway as a Possible Biological Link Between Cancer and Major Depression
Current Angiogenesis (Discontinued) Genetic Techniques for Pharmacogenetic Analyses
Current Pharmaceutical Design Intelligent Hydrogels for Drug Delivery System
Recent Patents on Drug Delivery & Formulation Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma on Cirrhosis: State of the Art and Future Perspectives
Recent Patents on Anti-Cancer Drug Discovery Patent Selections
Recent Patents on Biomedical Engineering (Discontinued) In-silico Designing, ADMET Analysis, Synthesis and Biological Evaluation of Novel Derivatives of Diosmin Against Urease Protein and Helicobacter pylori Bacterium
Current Topics in Medicinal Chemistry Alzheimer's Disease: Related Targets, Synthesis of Available Drugs, Bioactive Compounds Under Development and Promising Results Obtained from Multi-target Approaches
Current Drug Targets A Rationale for the Use of Proton Pump Inhibitors as Antineoplastic Agents
Current Pharmaceutical Design Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results
Current Medicinal Chemistry Emerging Vascular Risk Factors in Women: Any Differences from Men?
Current Medicinal Chemistry